A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis

被引:54
作者
Brant, Steven R.
Wang, Ming-Hsi
Rawsthorne, Patricia
Sargent, Michael
Datta, Lisa Wu
Nouvet, Franklin
Shugart, Yin Yao
Bernstein, Charles N.
机构
[1] Johns Hopkins Univ, Sch Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21231 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21231 USA
[4] Univ Manitoba, Gastroenterol Sect, Winnipeg, MB R3T 2N2, Canada
[5] Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB R3E 0V9, Canada
关键词
D O I
10.1111/j.1572-0241.2006.00926.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Multiple established Crohn's disease (CD) and ulcerative colitis (UC) risk factors including family history, tobacco use, Jewish ethnicity, urban residency, and CARD15/NOD2 mutations have been evaluated singly and in hospital-based observational studies. The goal of this study was to assess the relative contributions of all these risk factors jointly in a nonreferral, population-based cohort derived from a population epidemiologic database. METHODS: CD (N = 232) and UC (N = 121) subjects were ascertained from our population-based IBD Registry derived from Manitoba Health, the single provincial insurer. Healthy controls (HC) (N = 336) were recruited via a 10:1 mailing matched for age, sex, and postal code. Ethnicity, tobacco use, family history, residency, and CARD15/NOD2 genotype status were determined. RESULTS: In both univariate analyses and analyses adjusted for all risk factors, CD was influenced independently by CARD15/NOD2 heterozygote and homozygote/compound-heterozygote status (adjusted odds ratios [OR] 3.7 and 40.0, respectively), Jewish ethnicity (OR 18.5), CD family history (OR 6.2), and smoking (OR 3.0 current and 1.7 ex-smoker, respectively). Penetrance for homozygote/compound-heterozygotes was 4.9%, heterozygotes 0.54%, and wild types 0.184%. Population attributable risk for CARD15 was 26.7% and current tobacco use was 46.8%. A tobacco-CARD15 interaction was not observed. UC was influenced by Jewish ethnicity (OR 37.1), and by family history (OR 2.6), ex-smoker status (OR 1.9), and CARD15/NOD2 heterozygote or homozygote/compound-heterozygote status (OR 1.9 and 6.4, respectively) in adjusted analyses only. CONCLUSIONS: CARD15/NOD2, family history, smoking, and Jewish ethnicity are independent risk factors for CD. Examination of these risk factors together in a single population-based cohort has provided initial data for population epidemiological characterization and genetic counseling uses.
引用
收藏
页码:313 / 323
页数:11
相关论文
共 60 条
[1]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[2]   The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis:: An *IG-IBD study [J].
Andruilli, A ;
Annese, V ;
Latiano, A ;
Palmieri, O ;
Fortina, P ;
Ardizzone, S ;
Cottone, M ;
D'Inca, R ;
Riegler, G .
GASTROENTEROLOGY, 2004, 126 (02) :625-627
[3]   Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy -: An Italian Group for Inflammatory Bowel Disease Study [J].
Annese, V ;
Palmieri, O ;
Latiano, A ;
Ardizzone, S ;
Castiglione, F ;
Cottone, M ;
D'Incà, R ;
Gionchetti, P ;
Papi, C ;
Riegler, G ;
Vecchi, M ;
Andriulli, A .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (02) :121-124
[4]  
[Anonymous], 1982, CASE CONTROL STUDIES
[5]   NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? [J].
Arnott, IDR ;
Nimmo, ER ;
Drummond, HE ;
Fennell, J ;
Smith, BRK ;
MacKinlay, E ;
Morecroft, J ;
Anderson, N ;
Kelleher, D ;
O'Sullivan, M ;
McManus, R ;
Satsangi, J .
GENES AND IMMUNITY, 2004, 5 (05) :417-425
[6]   The epidemiology of inflammatory bowel disease in Canada: A population-based study [J].
Bernstein, Charles N. ;
Wajda, Andre ;
Svenson, Lawrence W. ;
MacKenzie, Adrian ;
Koehoorn, Mieke ;
Jackson, Maureen ;
Fedorak, Richard ;
Israel, David ;
Blanchard, James F. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07) :1559-1568
[7]   The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study [J].
Bernstein, CN ;
Wajda, A ;
Blanchard, JF .
GASTROENTEROLOGY, 2005, 129 (03) :827-836
[8]   The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study [J].
Bernstein, CN ;
Blanchard, JF ;
Leslie, W ;
Wajda, A ;
Yu, BN .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :795-799
[9]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[10]  
Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735